| Date | Time | Source | | | 05/24/2022 | 4:05PM | GLOBE | Intricon Announces Completion of Acquisition by an Affiliate of Altaris Capital Partners
ARDEN HILLS, Minn., May 24, 2022 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ: IIN), an international joint development manufacturer engaged in designing, developing, engineering, manufacturing, and packaging miniature interventional, implantable and body-worn medical devices, today announced the completion of its... More...>> |
| 02/28/2022 | 8:40AM | GLOBE | Intricon Reports Fourth Quarter and Full Year 2021 Results
ARDEN HILLS, Minn., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ: IIN), an international joint development manufacturer engaged in designing, developing, engineering, manufacturing, and packaging miniature interventional, implantable and body-worn medical devices, today announced financial results for... More...>> |
| 02/28/2022 | 8:35AM | GLOBE | Intricon Enters into Agreement to be Acquired by an Affiliate of Altaris Capital Partners for $241 Million
ARDEN HILLS, Minn., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ: IIN), an international joint development manufacturer engaged in designing, developing, engineering, manufacturing, and packaging miniature interventional, implantable and body-worn medical devices, today announced that it has entered into... More...>> |
| 11/09/2021 | 4:05PM | GLOBE | Intricon to Present at the Virtual 2021 Stifel Healthcare Conference
ARDEN HILLS, Minn., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ: IIN), an international joint development manufacturer engaged in designing, developing, engineering, manufacturing, and packaging miniature interventional, implantable and body-worn medical devices, today announced that Scott Longval, Intricon’s... More...>> |
| 11/08/2021 | 4:05PM | GLOBE | Intricon Reports Third Quarter 2021 Results
ARDEN HILLS, Minn., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ: IIN), an international joint development manufacturer engaged in designing, developing, engineering, manufacturing, and packaging miniature interventional, implantable and body-worn medical devices, today announced financial results for... More...>> |
| 10/29/2021 | 4:05PM | GLOBE | Intricon Announces CFO Departure and Preliminary Third Quarter 2021 Revenue
ARDEN HILLS, Minn., Oct. 29, 2021 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ: IIN), an international joint development manufacturer engaged in designing, developing, engineering, manufacturing, and packaging miniature interventional, implantable and body-worn medical devices, announced today that Ellen Scipta has... More...>> |
| 10/25/2021 | 4:05PM | GLOBE | Intricon to Announce 2021 Third Quarter Results on Monday, November 8, 2021
ARDEN HILLS, Minn., Oct. 25, 2021 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ: IIN), an international company engaged in designing, developing, engineering and manufacturing miniature interventional, implantable and body-worn medical devices, today announced that it will release its 2021 third quarter results on Monday... More...>> |
| 10/20/2021 | 4:05PM | GLOBE | Intricon Applauds FDA's Proposal to Improve Access to Hearing Aid Technology for Millions of Americans, Paving the Way for Over-the-Counter Hearing Aids
OTC Hearing Aid Act designed to offer greater public access to hearing aids at a lower costIntricon well positioned to provide the ecosystem necessary to deliver high customer satisfaction ARDEN HILLS, Minn., Oct. 20, 2021 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ: IIN), a joint development manufacturer of micromedical... More...>> |
| 09/30/2021 | 4:05PM | GLOBE | Intricon Self-Fitting Technology for Over-The-Counter Hearing Aids Clears Clinical Trial Milestone
ARDEN HILLS, Minn., Sept. 30, 2021 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ: IIN), a joint development manufacturer of micromedical technology for use in interventional, implantable, and body-worn medical devices, announced that it has achieved a critical milestone in the clinical study of its proprietary software... More...>> |
| 08/09/2021 | 4:05PM | GLOBE | Intricon Reports Second Quarter 2021 Results
ARDEN HILLS, Minn., Aug. 09, 2021 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ: IIN), an international joint development manufacturer engaged in designing, developing, engineering, manufacturing, and packaging miniature interventional, implantable and body-worn medical devices, today announced financial results for... More...>> |
| 08/09/2021 | 8:00AM | GLOBE | Intricon Hires David Liebl as Vice President of R&D
ARDEN HILLS, Minn., Aug. 09, 2021 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ: IIN), an international company engaged in designing, developing, engineering, and manufacturing miniature interventional, implantable and body-worn medical devices, today announced that David Liebl has joined the company as Vice President... More...>> |
| 07/26/2021 | 4:05PM | GLOBE | Intricon to Announce 2021 Second Quarter Results on Monday, August 9, 2021
ARDEN HILLS, Minn., July 26, 2021 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ: IIN), an international company engaged in designing, developing, engineering and manufacturing miniature interventional, implantable and body-worn medical devices, today announced that it will release its 2021 second quarter results on Monday... More...>> |
| 05/10/2021 | 4:05PM | GLOBE | Intricon Reports First Quarter 2021 Results
ARDEN HILLS, Minn., May 10, 2021 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ: IIN), an international company engaged in designing, developing, engineering, manufacturing, and packaging miniature interventional, implantable and body-worn medical devices, today announced financial results for its first quarter ended... More...>> |
| 04/26/2021 | 4:05PM | GLOBE | Intricon to Announce 2021 First Quarter Results on Monday, May 10, 2021
ARDEN HILLS, Minn., April 26, 2021 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ: IIN), an international company engaged in designing, developing, engineering and manufacturing miniature interventional, implantable and body-worn medical devices, today announced that it will release its 2021 first quarter results on Monday... More...>> |
|